References
- National Statistics Office republic of Korea. 2005 Annual report on the cause of death statistics, 2006
- Castelli WP, Garrisson RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The framingham study. JAMA 256: 2835-2838, 1986 https://doi.org/10.1001/jama.256.20.2835
- Glowinska B, Urban M, Koput A. Cardiovascular risk factors in children with obesity, hypertension and diabetes: lipoprotein (a) levels and body mass index correlate with family history of cardiovascular disease. Eur J Pediatr 161: 511-518, 2002 https://doi.org/10.1007/s00431-002-1040-7
- Kaplan NM. The deadly quartet. Arch Intern Med 149: 1514-1520, 1989 https://doi.org/10.1001/archinte.149.7.1514
- Poulter N. Coronary heart disease is a multifactorial disease. Am J Hypertens 12: S92-S95, 1999
- Grundy SM. Cholesterol and coronary heart disease: a new era. J Am Med Assoc 256: 2849-2858, 1986 https://doi.org/10.1001/jama.256.20.2849
- Neaton JD, Kuller LH, Wentworth D, Borhani NO. Total and cardiovascular mortality in relation to cigarette smoking, plasma cholesterol concentration and diastolic blood pressure among black and white males followed up for five years. Am Heart J 108: 759-769, 1984 https://doi.org/10.1016/0002-8703(84)90669-0
- Chapman MJ. Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease. Pharmacol Ther 111: 893-908, 2006 https://doi.org/10.1016/j.pharmthera.2006.02.003
- Despres JP, Lemicux I, Dagenais GR, Cantin B, Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis 153: 263-272, 2000 https://doi.org/10.1016/S0021-9150(00)00603-1
- Lim S, Lee EJ, Koo BK, Cho SI, Park KS, Jang HC, Kim SY, Lee HK. Increasing trends of metabolic syndrome in Korea based on Korean National Health and Nutrition Examination Surveys. J Kor Diabetes Assoc 29: 432-439, 2005
- Kim WB. Thyroid dysfunction, lipids and atherosclerosis. Korean J Med 64(4): 371-373, 2003
- Kritchevsky D. Vegetable protein and atherosclerosis. J Am Oil Chemists' Soc 56: 135-140, 1979 https://doi.org/10.1007/BF02671435
- Sirtori CR, Agradi E, Conti F, Mantero O, Gatti E. Soybean-protein diet in the treatment of type-II hyperlipoproteinaemia. Lancet 5; 1(8006): 275-277, 1977
- Sirtori CR, Gatti E, Mantero O, Conti F, Agradi E, Tremoli E, Sirtori M, Fraterrigo L, Tavazzi L, Kritchevsky D. Clinical experience with the soybean protein diet in the treatment of hypercholesterolemia. Am J Clin Nutr 32(8): 1645-1658, 1979 https://doi.org/10.1093/ajcn/32.8.1645
- Lee HJ. Health functional peptides from milk products. Korean Dairy Techno 16(2): 98-105, 1998
- Terpstra AHM, Hermus AJJ, West CE. Dietary protein and cholesterol metabolism in rabbits and rats. In: Current Topics in Nutrition and Disease: Animal and Vegetable proteins in Lipid Metabolism, pp.19-49, Alan RLiss-Inc. New York, 1983
- Han ES, Lee HJ, Shon DH. Effect of surface hydrophobicity of soybean peptides on the concentration of serum cholesterol and fecal steroid extraction in rats. Korean J Food Sci Technol 25(5): 571-575, 1993
- Lee HM, Chang UJ. Effect of corn peptide on the lipid metabolism in rats. Korean J Dietary Culture 16(5): 416-422, 2001
- American Institute of Nutrition. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J Nutr 107(7): 1340-1348, 1977 https://doi.org/10.1093/jn/107.7.1340
- Reitman S, Frankel S. Methods of enzymatic analysis, pp.760-763, Academic Press. New York, 1975
- Sale FO, Marchesini S, Fishman PH, Berra B. A sensitive enzymatic assay for determination of cholesterol in lipid extracts. Anal Biochem 142: 347-350, 1984 https://doi.org/10.1016/0003-2697(84)90475-5
- Friedewald WT, Levey RI. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972
- Steel RGD, Torrie JH. Principles and procedures of statistics, pp.55-60, McGraw-Hill. New York, 1989
- Hasegawa K, Larson JL, White WJ, Clifford CB. Baseline data comparing CD (SD) IGS rats supplied from Charles River Japan, Charles River UK and Charles River USA, pp.9-18, 2001
- Nishizawa N, Fudamoto Y. The elevation of plasma concentration of high density lipoprotein cholesterol in mice fed with protein from proso millet. Biosci Biotechnol Biochem 59(2): 333-335, 1995 https://doi.org/10.1271/bbb.59.333
- Sirtori CR, Zucchi-Dentone C, Sirtori M, Gatti E, Descovich GC, Gaddi A, Cattin L, Da Col PG, Senin U, Mannanino E, Avellone G, Colombo L, Fragiacomo C, Noseda G, Lenzi S. Cholesterollowering and HDL-raising properties of lecithinated soy proteins in type II hyperlipidemic patient. Ann Nutr Metab 29: 348-357, 1985 https://doi.org/10.1159/000176991
- Tall AR. Plasma high density lipoproteins metabolism and relationship to atherogenesis. J Clin Invest 86: 379-384, 1990 https://doi.org/10.1172/JCI114722
- Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoproteins A-I and B, and HDL density subfractions: the Athrosclerosis Risk in Communities (ARIC) Study. Circulation 104: 1108-1113, 2001 https://doi.org/10.1161/hc3501.095214
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Execute Summary of the Third Report of the National Cholesterol Education Program (NECP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 285(19): 2486-2496, 2001 https://doi.org/10.1001/jama.285.19.2486